These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 27214240)
1. Predictive role of the overexpression for CXCR4, C-Met, and VEGF-C among breast cancer patients: A meta-analysis. Wang F; Li S; Zhao Y; Yang K; Chen M; Niu H; Yang J; Luo Y; Tang W; Sheng M Breast; 2016 Aug; 28():45-53. PubMed ID: 27214240 [TBL] [Abstract][Full Text] [Related]
2. The impact of chemokine receptor CXCR4 on breast cancer prognosis: a meta-analysis. Xu TP; Shen H; Liu LX; Shu YQ Cancer Epidemiol; 2013 Oct; 37(5):725-31. PubMed ID: 23763828 [TBL] [Abstract][Full Text] [Related]
3. Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature. Wang J; Guo Y; Wang B; Bi J; Li K; Liang X; Chu H; Jiang H Mol Biol Rep; 2012 Dec; 39(12):11153-65. PubMed ID: 23054001 [TBL] [Abstract][Full Text] [Related]
4. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence. Holm NT; Byrnes K; Li BD; Turnage RH; Abreo F; Mathis JM; Chu QD J Surg Res; 2007 Jul; 141(1):53-9. PubMed ID: 17574038 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial. Linardou H; Kalogeras KT; Kronenwett R; Alexopoulou Z; Wirtz RM; Zagouri F; Scopa CD; Gogas H; Petraki K; Christodoulou C; Pavlakis K; Koutras AK; Samantas E; Patsea H; Pectasides D; Bafaloukos D; Fountzilas G Anticancer Res; 2015 Jul; 35(7):4023-36. PubMed ID: 26124351 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients. Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of VEGF-C immunohistochemical expression in breast cancer: a meta-analysis. Gao S; Ma JJ; Lu C Tumour Biol; 2014 Feb; 35(2):1523-9. PubMed ID: 24078449 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic significance of c-Met overexpression in breast cancer. Zhao X; Qu J; Hui Y; Zhang H; Sun Y; Liu X; Zhao X; Zhao Z; Yang Q; Wang F; Zhang S Oncotarget; 2017 Aug; 8(34):56758-56767. PubMed ID: 28915628 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis. Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045 [TBL] [Abstract][Full Text] [Related]
11. C-Met as a potential novel prognostic marker in squamous cell carcinoma and adenocarcinoma of esophagus: evidence from a meta-analysis. Ren JL; Wu HF; Wang WJ; Hu GM; Gu B; Zhang M; Wang YX Panminerva Med; 2017 Mar; 59(1):97-106. PubMed ID: 27636117 [TBL] [Abstract][Full Text] [Related]
12. The prognostic value of vascular endothelial growth factor in ovarian cancer: a systematic review and meta-analysis. Yu L; Deng L; Li J; Zhang Y; Hu L Gynecol Oncol; 2013 Feb; 128(2):391-6. PubMed ID: 23142075 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases. Yan S; Jiao X; Zou H; Li K Diagn Pathol; 2015 Jun; 10():62. PubMed ID: 26047809 [TBL] [Abstract][Full Text] [Related]
14. Combined Wnt/β-catenin, Met, and CXCL12/CXCR4 signals characterize basal breast cancer and predict disease outcome. Holland JD; Györffy B; Vogel R; Eckert K; Valenti G; Fang L; Lohneis P; Elezkurtaj S; Ziebold U; Birchmeier W Cell Rep; 2013 Dec; 5(5):1214-27. PubMed ID: 24290754 [TBL] [Abstract][Full Text] [Related]
15. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis. Lv S; Yang Y; Kwon S; Han M; Zhao F; Kang H; Dai C; Wang R Histopathology; 2014 Apr; 64(5):701-12. PubMed ID: 24422942 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of vascular endothelial growth factor expression in women with ovarian cancer: A meta-analysis. Hui G; Meng M J BUON; 2015; 20(3):870-8. PubMed ID: 26214642 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of High VEGF-C Expression for Patients with Breast Cancer: An Update Meta Analysis. Zhang Z; Luo G; Tang H; Cheng C; Wang P PLoS One; 2016; 11(11):e0165725. PubMed ID: 27812168 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of High CXCR4 Expression in Renal Cell Carcinoma: A System Review and Meta-Analysis. Du Y; Long Q; Guan B; Mu L Dis Markers; 2015; 2015():568980. PubMed ID: 26526157 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of vascular endothelial growth factor in patients with head and neck cancer: A meta-analysis. Zang J; Li C; Zhao LN; Shi M; Zhou YC; Wang JH; Li X Head Neck; 2013 Oct; 35(10):1507-14. PubMed ID: 22987573 [TBL] [Abstract][Full Text] [Related]
20. The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis. Lin SC; Gan ZH; Yao Y; Min da L PLoS One; 2015; 10(8):e0136374. PubMed ID: 26305693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]